Tomonori Ishii

机构：Tohoku University, Tohoku University Hospital, Tohoku Medical and Pharmaceutical University Hospital, Tohoku Medical and Pharmaceutical University · ORCID：0000-0001-5361-5824

发表论文 260 篇 · 总被引 6045 次 · h-index 38

代表论文

• A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis (2025 · New England Journal of Medicine · 被引 103)
• Safety, pharmacokinetics, biomarker response and efficacy of E6742: a dual antagonist of Toll-like receptors 7 and 8, in a first in patient, randomised, double-blind, phase I/II study in systemic lupus erythematosus (2024 · RMD Open · 被引 24)
• Association of methotrexate polyglutamates concentration with methotrexate efficacy and safety in patients with rheumatoid arthritis treated with predefined dose: results from the MIRACLE trial (2024 · Annals of the Rheumatic Diseases · 被引 14)
• LBA0001 EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH GIANT CELL ARTERITIS (SELECT-GCA): A DOUBLE-BLIND, RANDOMIZED CONTROLLED PHASE 3 TRIAL (2024 · Annals of the Rheumatic Diseases · 被引 13)
• Real-world safety and effectiveness of mepolizumab for patients with eosinophilic granulomatosis with polyangiitis in Japan: Long-term observation of the MARS study (2024 · Modern Rheumatology · 被引 12)
• Tafamidis Medication Adherence and Persistence in Patients with Transthyretin Amyloid Cardiomyopathy in Japan (2024 · ESC Heart Failure · 被引 10)